NEW YORK (GenomeWeb) – HTG Molecular Diagnostics reported on Tuesday a 5 percent drop in second quarter revenues as a decline in consumable sales more than offset an increase in revenues from biopharmaceutical partners.

For the three-month period ended June 30, HTG's revenues slipped to $1.8 million from $1.9 million in the same quarter last year. Service revenues grew to $1.4 million from $1.3 million, while product revenues fell to $407,177 from $577,127.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Jun
14

This webinar will discuss an effort underway at the University of North Carolina Medical Center's to overcome limitations in the hematological genomic testing workflow with artificial intelligence (AI) from Sophia Genetics.

Jun
19

This webinar will provide evidence for the use of RNA in situ hybridization (RNA ISH) as a replacement for immunohistochemistry (IHC) in cancer research and diagnostic applications.

Jun
26

This webinar outlines a study that sought to characterize the landscape of alternative polyadenylation (APA) in the lung cancer transcriptome in order to gain insight into the role of APA in cancer progression.

Jun
28
Sponsored by
PerkinElmer

This webinar will review a standardized, high-throughput, and fully automated library prep protocol for human metagenomic analysis.